Neurocrine Biosciences shares owned by Bellevue Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $215M | 1.9M | 115.22 |
| 2024-06-30 | $261M | 1.9M | 137.67 |
| 2024-03-31 | $284M | 2.1M | 137.92 |
| 2023-12-31 | $320M | 2.4M | 131.76 |
| 2023-09-30 | $291M | 2.6M | 112.50 |
| 2023-06-30 | $246M | 2.6M | 94.30 |
| 2023-03-31 | $265M | 2.6M | 101.22 |
| 2022-12-31 | $331M | 2.8M | 119.44 |
| 2022-09-30 | $303M | 2.9M | 106.21 |
| 2022-06-30 | $277M | 2.8M | 97.48 |
| 2022-03-31 | $283M | 3.0M | 93.75 |
| 2021-12-31 | $271M | 3.2M | 85.17 |
| 2021-09-30 | $288M | 3.0M | 95.92 |
| 2021-06-30 | $294M | 3.0M | 97.32 |
| 2021-03-31 | $318M | 3.3M | 97.25 |
| 2020-12-31 | $326M | 3.4M | 95.85 |
| 2020-09-30 | $317M | 3.3M | 96.16 |
| 2020-06-30 | $392M | 3.2M | 122.00 |
| 2020-03-31 | $282M | 3.3M | 86.55 |
| 2019-12-31 | $357M | 3.3M | 107.49 |
| 2019-09-30 | $297M | 3.3M | 90.11 |
| 2019-06-30 | $299M | 3.5M | 84.43 |
| 2019-03-31 | $1.8M | 20k | 88.12 |
| 2018-12-31 | $2.9M | 40k | 71.41 |
| 2018-09-30 | $5.1M | 42k | 122.96 |
| 2018-06-30 | $4.3M | 44k | 98.23 |
| 2018-03-31 | $4.4M | 54k | 82.93 |
| 2017-12-31 | $4.2M | 55k | 77.60 |
| 2017-09-30 | $3.4M | 56k | 61.29 |
| 2017-06-30 | $2.2M | 47k | 46.00 |
| 2017-03-31 | $2.9M | 68k | 43.29 |
| 2016-12-31 | $2.9M | 75k | 38.69 |
| 2016-09-30 | $2.9M | 58k | 50.64 |
| 2016-06-30 | $2.6M | 58k | 45.45 |
| 2016-03-31 | $2.6M | 65k | 39.55 |